Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in stroke management.

G W Albers1, M J Alberts, J P Broderick

  • 1Stanford University Medical University, Palo Alto, CA, USA.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|September 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Venous Outflow Predicts Functional Outcomes in Patients with Acute Ischemic Stroke Treated by Thrombectomy.

AJNR. American journal of neuroradiology·2023
Same author

Migraine-Associated Common Genetic Variants Confer Greater Risk of Posterior vs. Anterior Circulation Ischemic Stroke☆.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2022
Same author

Tissue at Risk and Ischemic Core Estimation Using Deep Learning in Acute Stroke.

AJNR. American journal of neuroradiology·2021
Same author

Hypoperfusion intensity ratio correlates with angiographic collaterals in acute ischaemic stroke with M1 occlusion.

European journal of neurology·2020
Same author

Detailed phenotyping of posterior vs. anterior circulation ischemic stroke: a multi-center MRI study.

Journal of neurology·2019
Same author

Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis.

AJNR. American journal of neuroradiology·2019
Same journal

Admission Cognitive Function Independently Predicts Discharge Walking Function and Functional Independence After Stroke: A Multicenter Retrospective Cohort Study.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same journal

Association Between Race, Ethnicity, and Sex with Prehospital Identification and Outcomes of Patients with Stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same journal

Direct Oral Anticoagulants versus Aspirin for Prevention of Overt and Covert Cerebral Infarction: A Meta-Analysis.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same journal

Efficacy of Pharyngeal Balloon Muscle Resistance Treatment in Post-Stroke Dysphagia: A Randomized Controlled Trial.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same journal

Detection of atrial fibrillation via adhesive single-lead ECG vs. Holter monitoring in embolic stroke of undetermined source: the AVANT-GARDE trial.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same journal

Predictive value of the waist-to-height ratio and HbA1c product for incident stroke: a stratified analysis by blood pressure status.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
See all related articles

Recent stroke research highlights effective risk factor modification for prevention and introduces intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke treatment within 3 hours. While neuroprotective agents show promise, rapid administration is key for all acute stroke therapies.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Stroke incidence can be substantially reduced through modification of identified risk factors.
  • Emerging risk factors include elevated plasma homocysteine, antiphospholipid antibodies, and genetic factors.
  • Intravenous tissue plasminogen activator (t-PA) is the sole FDA-approved acute ischemic stroke treatment.

Purpose of the Study:

  • To review recent advances in stroke treatment and prevention.
  • To discuss the efficacy and challenges of current acute stroke therapies, including t-PA.
  • To explore the potential of neuroprotective agents and the importance of rapid treatment administration.

Main Methods:

  • Review of recent studies on stroke risk factors and treatment modalities.

Related Experiment Videos

  • Analysis of clinical trial outcomes for thrombolytic and neuroprotective agents.
  • Discussion of the development of acute stroke teams for timely intervention.

    • Main Results:

    • Modification of stroke risk factors significantly reduces stroke incidence.
    • Intravenous t-PA is effective for acute ischemic stroke if administered within 3 hours, though its risks and benefits require careful consideration.
    • Neuroprotective agents have shown limited success in human clinical trials despite promising animal model results.

    Conclusions:

    • Rapid administration of both thrombolytic and neuroprotective treatments is crucial for acute stroke management.
    • The development of specialized acute stroke teams is essential for facilitating prompt diagnosis and treatment.
    • Ongoing research into novel neuroprotective agents and improved clinical trial designs holds promise for future therapeutic breakthroughs.